These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 28350743)

  • 21. Prognosis of patients with ascites after PleurX insertion: an observational study.
    Riedel AN; Kimer N; Hobolth L; Gluud LL
    Scand J Gastroenterol; 2018 Mar; 53(3):340-344. PubMed ID: 29411667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PleurX peritoneal catheter drainage system for vacuum-assisted drainage of treatment-resistant, recurrent malignant ascites: a NICE Medical Technology Guidance.
    White J; Carolan-Rees G
    Appl Health Econ Health Policy; 2012 Sep; 10(5):299-308. PubMed ID: 22779402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous peritoneal drainage of large-volume ascites.
    Van Thiel DH; Moore CM; Garcia M; George M; Nadir A
    Dig Dis Sci; 2011 Sep; 56(9):2723-7. PubMed ID: 21735084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indwelling catheters for the management of malignant ascites.
    Lee A; Lau TN; Yeong KY
    Support Care Cancer; 2000 Nov; 8(6):493-9. PubMed ID: 11094995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of indwelling pleural/peritoneal catheter in the management of malignant ascites: a retrospective study of 48 patients.
    Chan KP; Badiei A; Tan CPS; Fitzgerald DB; Stanley C; Fysh ETH; Shrestha R; Muruganandan S; Read CA; Thomas R; Lee YCG
    Intern Med J; 2020 Jun; 50(6):705-711. PubMed ID: 31566871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Impact of Tunneled Catheters for Ascites and Peritoneal Carcinomatosis on Patient Rehospitalizations.
    Qu C; Xing M; Ghodadra A; McCluskey KM; Santos E; Kim HS
    Cardiovasc Intervent Radiol; 2016 May; 39(5):711-716. PubMed ID: 26662561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peritoneal catheter for continuous drainage of ascites in advanced cancer patients.
    Mercadante S; Intravaia G; Ferrera P; Villari P; David F
    Support Care Cancer; 2008 Aug; 16(8):975-8. PubMed ID: 18449571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peritoneal Dialysis Catheters to Treat Refractory Non-Malignant Ascites.
    Hingwala J; Whitlock R; Dunsmore S; Armstrong S; Tangri N; Komenda P
    Perit Dial Int; 2017; 37(4):481-482. PubMed ID: 28676515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Transjugular intrahepatic portosystemic shunt in the treatment of refractory ascites in 21 patients].
    Vandistel G; Nevens F; Stockx L; Raat H; Wilms G; Fevery J
    Ned Tijdschr Geneeskd; 1996 Dec; 140(49):2455-8. PubMed ID: 8999346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Permanent indwelling peritoneal access device for the management of malignant ascites.
    Sabatelli FW; Glassman ML; Kerns SR; Hawkins IF
    Cardiovasc Intervent Radiol; 1994; 17(5):292-4. PubMed ID: 7529660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Permanent catheters for recurrent ascites-a critical and systematic review of study methodology.
    Christensen L; Wildgaard L; Wildgaard K
    Support Care Cancer; 2016 Jun; 24(6):2767-79. PubMed ID: 26928443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomised clinical trial: palliative long-term abdominal drains vs large-volume paracentesis in refractory ascites due to cirrhosis.
    Macken L; Bremner S; Gage H; Touray M; Williams P; Crook D; Mason L; Lambert D; Evans CJ; Cooper M; Timeyin J; Steer S; Austin M; Parnell N; Thomson SJ; Sheridan D; Wright M; Isaacs P; Hashim A; Verma S
    Aliment Pharmacol Ther; 2020 Jul; 52(1):107-122. PubMed ID: 32478917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites.
    Ochs A; Rössle M; Haag K; Hauenstein KH; Deibert P; Siegerstetter V; Huonker M; Langer M; Blum HE
    N Engl J Med; 1995 May; 332(18):1192-7. PubMed ID: 7700312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of non-ovarian cancer malignant ascites through indwelling catheter drainage.
    Gu X; Zhang Y; Cheng M; Liu M; Zhang Z; Cheng W
    BMC Palliat Care; 2016 Apr; 15():44. PubMed ID: 27103467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current treatment options of refractory ascites in liver cirrhosis - A systematic review and meta-analysis.
    Will V; Rodrigues SG; Berzigotti A
    Dig Liver Dis; 2022 Aug; 54(8):1007-1014. PubMed ID: 35016859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
    Ginès P; Uriz J; Calahorra B; Garcia-Tsao G; Kamath PS; Del Arbol LR; Planas R; Bosch J; Arroyo V; Rodés J
    Gastroenterology; 2002 Dec; 123(6):1839-47. PubMed ID: 12454841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreas Adenocarcinoma: Ascites, Clinical Manifestations, and Management Implications.
    Hicks AM; Chou J; Capanu M; Lowery MA; Yu KH; O'Reilly EM
    Clin Colorectal Cancer; 2016 Dec; 15(4):360-368. PubMed ID: 27262896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ascites: diagnosis and management.
    Hou W; Sanyal AJ
    Med Clin North Am; 2009 Jul; 93(4):801-17, vii. PubMed ID: 19577115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Automated low flow pump system for the treatment of refractory ascites: a single-center experience.
    Thomas MN; Sauter GH; Gerbes AL; Stangl M; Schiergens TS; Angele M; Werner J; Guba M
    Langenbecks Arch Surg; 2015 Dec; 400(8):979-83. PubMed ID: 26566989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New therapeutic paradigm and concepts for patients with cirrhotic refractory ascites].
    Wang SZ; Ding HG
    Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):249-253. PubMed ID: 28494541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.